Clinical Trial

NICardipine for Fast Achievement of Systolic BP Targets in ICH

Study acronym: NICFAST
Recruiting Phase 4
View on ClinicalTrials.gov →
Summary
Quality improvement study with a quasi-randomized design. The study monitors the effect of a gradually implemented treatment algorithm prioritizing intravenous antihypertensives (e.g., nicardipine) over long-acting nitrate patches. It aims to increase the proportion of patients reaching target systolic BP \<140 mmHg within 1 hour of hospital admission while monitoring safety, clinical outcomes, and healthcare resource utilization.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-06-27.
Status change: Not Yet Recruiting → Recruiting 2026-06-22
Trial Details
NCT Number NCT07044232
Lead Sponsor Aarhus University Hospital
Conditions Intracerebral Haemorrhage
Enrollment 88 participants
Start Date 2025-10-01
Primary Completion 2026-09-30 (estimated)
Study Completion 2027-09-30 (estimated)
Updated on ClinicalTrials.gov 2026-06-24